These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF. Diabetes; 2000 Mar; 49(3):399-408. PubMed ID: 10868961 [Abstract] [Full Text] [Related]
32. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients. Rizkalla SW, Elgrably F, Tchobroutsky G, Slama G. Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670 [Abstract] [Full Text] [Related]
35. Comparison of insulin secretory patterns in obese nondiabetic LA/N-cp and obese diabetic SHR/N-cp rats. Role of hyperglycemia. Recant L, Voyles NR, Timmers KI, Bhathena SJ, Solomon D, Wilkins S, Michaelis OE. Diabetes; 1989 Jun; 38(6):691-7. PubMed ID: 2656338 [Abstract] [Full Text] [Related]
36. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Kjems LL, Holst JJ, Vølund A, Madsbad S. Diabetes; 2003 Feb; 52(2):380-6. PubMed ID: 12540611 [Abstract] [Full Text] [Related]
37. [Stimulation of insulin secretion in diabetics using secretin]. Raptis S, Schröder KE, Faulhaber JD, Pfeiffer EF. Dtsch Med Wochenschr; 1968 Dec 13; 93(50):2420-4. PubMed ID: 5698974 [No Abstract] [Full Text] [Related]